Latest stories on AZN
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
CNBC Breaking67 · bullishproduct/pr
AstraZeneca Broadens US Growth Push
Bloomberg61 · neutralproduct/pr
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity | MDBH Stock News
StockTitan58 · neutralproduct/pr
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
TipRanks58 · neutralproduct/pr
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
Yahoo Top33 · bearishproduct/pr
AstraZeneca PLC (AZN) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026 - Slideshow
Seeking Alpha53 · neutralproduct/pr
AstraZeneca wins approval of Imfinzi for additional bladder cancer type
Seeking Alpha77 · bullishproduct/pr
AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real-World Data Could Mean for AZN Investors
TipRanks58 · neutralproduct/pr
AstraZeneca says FDA has delayed review of breast cancer therapy camizestrant
Seeking Alpha33 · bearishproduct/pr
AstraZeneca Wins Landmark U.S. Approval for Datroway in Hard-to-Treat Breast Cancer
TipRanks86 · bullishproduct/pr
AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins
Seeking Alpha77 · bullishearnings
AstraZeneca gains approval of Datroway as a first-line breast cancer treatment
Seeking Alpha77 · bullishproduct/pr
AbbVie, Merck, Astra among winners of EU drug recommendations this week
Seeking Alpha77 · bullishproduct/pr
AstraZeneca wins US FDA approval for hypertension drug Baxfendy
Seeking Alpha86 · bullishproduct/pr
Owkin Expands AstraZeneca Collaboration Around K Pro AI Platform
Yahoo Top61 · neutralproduct/pr
AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug
Yahoo Top33 · bearishproduct/pr